ClinTec began operations in Asia with the opening of our Indian office, located in Bangalore, in 2002. Since then we have built up a team of over 40 personnel in a range of functions from monitoring and project management, data management and medical writing to feasibility assessments and training.

ClinTec has performed several clinical studies in India including both local and global trials covering a wide variety of therapeutic areas, for example: oncology, haematological disorders, immunology, infectious disease and vaccine trials. In addition, we have performed over 60 Bioequivalence and Bioavailability studies involving 2500 patients in India. 

In addition to our extensive operation in India, we have historically worked in South Korea and the Philippines performing patient recruitment services for a global pharmaceutical company.

The growth of ClinTec has always been organic in order to fulfil the requirements of our clients and the opening new regional bases in Shanghai and Singapore will further enhance our portfolio and allow cooperation with a new client base.

Our global footprint in Asia extends to:
China / India / Thailand / South Korea / Philippines / Singapore / Malaysia

Why should you conduct studies in Asia Pacific?

- Highly qualified and trained Investigators and medical staff

- High recruitment potential due to treatment-naive patients

- Low study costs compared to other regions

- Large heterogeneous patient populations